Stock Market Reviews

Read and share opinions on SSKN (STRATA Skin Sciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
  Nov 13, 2025
• STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
  Nov 6, 2025
• STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update
  Nov 5, 2025
• STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements
  Oct 28, 2025
• Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides
  Oct 14, 2025
• Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis
  Oct 3, 2025
• STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis
  Sep 30, 2025
• New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences’ Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach
  Sep 22, 2025
• STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
  Sep 4, 2025
• STRATA Skin Sciences’ Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements
  Sep 4, 2025
• STRATA Skin Sciences Announces Pricing of $2.42 Million Registered Direct Offering of Common Stock Priced At-Market Under Nasdaq Rules
  Sep 3, 2025
• STRATA Skin Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
  Sep 2, 2025
• STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions
  Sep 2, 2025
• Analysts Just Made A Major Revision To Their STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Revenue Forecasts
  Aug 16, 2025
• STRATA Skin Sciences Second Quarter 2025 Earnings: Misses Expectations
  Aug 15, 2025
• STRATA Skin Sciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
  Aug 13, 2025
• STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients
  Aug 7, 2025
• STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update
  Jul 31, 2025